Treatment of chronic heart failure with perindopril in ethnic Sri Lankan patients by Thenabadu, P N, Bulumulle, J, Constantine, G R

Get full text

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study by Fessas, Petros, Kaseb, Ahmed, Wang, Yinghong, Saeed, Anwaar, Szafron, David, Jun, Tomi, Dharmapuri, Sirish, Rafeh Naqash, Abdul, Muzaffar, Mahvish, Navaid, Musharraf, Khan, Uqba, Lee, ChiehJu, Bulumulle, Anushi, Yu, Bo, Paul, Sonal, Nimkar, Neil, Bettinger, Dominik, Benevento, Francesca, Hildebrand, Hannah, Pressiani, Tiziana, Abugabal, Yehia I, Personeni, Nicola, Huang, Yi-Hsiang, Rimassa, Lorenza, Ang, Celina, Marron, Thomas, Pinato, David J

Get full text

Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma by Fessas, Petros, Naeem, Muntaha, Pinter, Matthias, Marron, Thomas U., Szafron, David, Balcar, Lorenz, Saeed, Anwaar, Jun, Tomi, Dharmapuri, Sirish, Gampa, Anuhya, Wang, Yinghong, Khan, Uqba, Muzaffar, Mahvish, Navaid, Musharraf, Lee, Pei-Chang, Bulumulle, Anushi, Yu, Bo, Paul, Sonal, Nimkar, Neil, Bettinger, Dominik, Hildebrand, Hannah, Abugabal, Yehia I., Pressiani, Tiziana, Personeni, Nicola, Nishida, Naoshi, Kudo, Masatoshi, Kaseb, Ahmed, Huang, Yi-Hsiang, Ang, Celina, Pillai, Anjana, Rimassa, Lorenza, Naqash, Abdul Rafeh, Sharon, Elad, Cortellini, Alessio, Pinato, David J.

Get full text

Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from r... by Pinato, David J., Marron, Thomas U., Mishra-Kalyani, Pallavi Shruti, Gong, Yutao, Wei, Guo, Szafron, David, Sharon, Elad, Saeed, Anwaar, Jun, Tomi, Dharmapuri, Sirish, Naqash, Abdul R., Peeraphatdit, Thoetchai, Gampa, Anuhya, Wang, Yinghong, Khan, Uqba, Muzaffar, Mahvish, Navaid, Musharraf, Lee, Chieh J., Lee, Pei-Chang, Bulumulle, Anushi, Yu, Bo, Paul, Sonal, Nimkar, Neil, Bettinger, Dominik, Hildebrand, Hannah, Abugabal, Yehia I., Pressiani, Tiziana, Personeni, Nicola, D'Alessio, Antonio, Kaseb, Ahmed O., Huang, Yi-Hsiang, Ang, Celina, Schneider, Julie, Pillai, Anjana, Rimassa, Lorenza, Goldberg, Kirsten B., Pazdur, Richard, Theoret, Marc, Lemery, Steven, Fashoyin-Aje, ‘Lola, Cortellini, Alessio, Pelosof, Lorraine

Get full text

Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy by Pinato, David J, Kaseb, Ahmed, Wang, Yinghong, Saeed, Anwaar, Szafron, David, Jun, Tomi, Dharmapuri, Sirish, Naqash, Abdul Rafeh, Muzaffar, Mahvish, Navaid, Musharraf, Khan, Uqba, Lee, ChiehJu, Bulumulle, Anushi, Yu, Bo, Paul, Sonal, Fessas, Petros, Nimkar, Neil, Bettinger, Dominik, Hildebrand, Hannah, Pressiani, Tiziana, Abugabal, Yehia I, Personeni, Nicola, Huang, Yi-Hsiang, Lozano-Kuehne, Jingky, Rimassa, Lorenza, Ang, Celina, Marron, Thomas U

Get full text

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade by Pinato, David J, Kaneko, Takahiro, Saeed, Anwaar, Pressiani, Tiziana, Kaseb, Ahmed, Wang, Yinghong, Szafron, David, Jun, Tomi, Dharmapuri, Sirish, Naqash, Abdul Rafeh, Muzaffar, Mahvish, Navaid, Musharraf, Lee, Chieh-Ju, Bulumulle, Anushi, Yu, Bo, Paul, Sonal, Nimkar, Neil, Bettinger, Dominik, Hildebrand, Hannah, Abugabal, Yehia I, Ang, Celina, Marron, Thomas U, Khan, Uqba, Personeni, Nicola, Rimassa, Lorenza, Huang, Yi-Hsiang

Get full text

Abstract 485: Early antibiotic exposure delays disease progression following immune checkpoint inhibitor therapy for hepatocellular carcinoma: Evidence from an observational study by Fessas, Petros, Naeem, Muntaha, Marron, Thomas U., Szafron, David, Sharon, Elad, Saeed, Anwar, Jun, Tomi, Dharmapuri, Sirish, Naqash, Abdul R., Peeraphatdit, Thoetchai, Gampa, Anuhya, Wang, Yinghong, Khan, Uqba, Muzaffar, Mahvish, Navaid, Musharraf, Lee, ChiehJu, Lee, Pei-Chang, Bulumulle, Anushi, Yu, Bo, Paul, Sonal, Nimkar, Neil, Bettinger, Dominik, Hildebrand, Hannah, Abugabal, Yehia I., Pressiani, Tiziana, Personeni, Nicola, Nishida, Naoshi, Kudo, Masatoshi, Kaseb, Ahmed, Huang, Yi-Hsiang, Ang, Celina, Pillai, Anjana, Rimassa, Lorenza, Pinato, David J.

Get full text

Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer by Sehgal, Kartik, Bulumulle, Anushi, Brody, Heather, Gill, Ritu R., Macherla, Shravanti, Qilleri, Aleksandra, McDonald, Danielle C., Cherry, Cynthia R., Shea, Meghan, Huberman, Mark S., VanderLaan, Paul A., Weiss, Glen J., Walker, Paul R., Costa, Daniel B., Rangachari, Deepa

Get full text

Treatment-related toxicity predicts for improved outcome in patients with hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitor therapy by Pinato, David J., Wang, Yinghong, Marron, Thomas U., Saeed, Anwaar, Jun, Tomi, Naqash, Abdul Rafeh, Dharmapuri, Sirish, Khan, Uqba, Benevento, Francesca, Navaid, Musharraf, Muzaffar, Mahvish, Lee, ChiehJu, Bulumulle, Anushi, Yu, Bo, Paul, Sonal, Nimkar, Neil, Dominik, Bettinger, Hildebrand, Hannah, Pressiani, Tiziana, Abugabal, Yehia, Personeni, Nicola, Kaseb, Ahmed, Huang, Yi-Hsiang, Ang, Celina, Allara, Elias, Rimassa, Lorenza

Get full text

AS054 - Treatment-related toxicity predicts for improved outcome in patients with hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitor therapy by Pinato, David J., Wang, Yinghong, Marron, Thomas U., Saeed, Anwaar, Jun, Tomi, Naqash, Abdul Rafeh, Dharmapuri, Sirish, Khan, Uqba, Benevento, Francesca, Navaid, Musharraf, Muzaffar, Mahvish, Lee, ChiehJu, Bulumulle, Anushi, Yu, Bo, Paul, Sonal, Nimkar, Neil, Dominik, Bettinger, Hildebrand, Hannah, Pressiani, Tiziana, Abugabal, Yehia, Personeni, Nicola, Kaseb, Ahmed, Huang, Yi-Hsiang, Ang, Celina, Allara, Elias, Rimassa, Lorenza

Get full text